November 06, 2014
Onxeo Quarterly Information as of September 30, 2014
Media
November 06, 2014
AEROCRINE AB RECEIVES US FDA MARKET CLEARANCE FOR NIOX VERO®
November 05, 2014
Q3 2014 General Market Overview
November 04, 2014
Nexstim Plc successfully completes its Initial Public Offering – subscriptions reach EUR 15.3 million with final offer price of EUR 6.35 per share
November 03, 2014
Nordic Nanovector strengthens management team to prepare for its next phase
October 30, 2014
Ultragenyx Granted EU Orphan Drug Designation for KRN23 for the Treatment of X-Linked Hypophosphatemia
October 30, 2014
Positive Phase II preliminary results of Validive® for the prevention of Severe Oral Mucositis in Head and Neck cancer patients
October 30, 2014
Cortendo Announces HealthCap Leads $11M (NOK 73.4M) Private Placement
October 23, 2014
Nordic Nanovector AS: Third quarter report 2014
October 23, 2014
HealthCap i unikt samarbetsprojekt “Agenda för hälsa och välstånd”